NO20033801L - Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser - Google Patents

Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser

Info

Publication number
NO20033801L
NO20033801L NO20033801A NO20033801A NO20033801L NO 20033801 L NO20033801 L NO 20033801L NO 20033801 A NO20033801 A NO 20033801A NO 20033801 A NO20033801 A NO 20033801A NO 20033801 L NO20033801 L NO 20033801L
Authority
NO
Norway
Prior art keywords
group
psychotic disorders
phenyl
prevention
treatment
Prior art date
Application number
NO20033801A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033801D0 (no
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20033801D0 publication Critical patent/NO20033801D0/no
Publication of NO20033801L publication Critical patent/NO20033801L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20033801A 2001-02-27 2003-08-26 Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser NO20033801L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
PCT/US2002/006119 WO2002067927A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (2)

Publication Number Publication Date
NO20033801D0 NO20033801D0 (no) 2003-08-26
NO20033801L true NO20033801L (no) 2003-10-22

Family

ID=26765939

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033801A NO20033801L (no) 2001-02-27 2003-08-26 Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser

Country Status (25)

Country Link
US (1) US6541513B2 (cg-RX-API-DMAC7.html)
EP (1) EP1401424B1 (cg-RX-API-DMAC7.html)
JP (1) JP4276841B2 (cg-RX-API-DMAC7.html)
KR (1) KR100886578B1 (cg-RX-API-DMAC7.html)
CN (1) CN1262271C (cg-RX-API-DMAC7.html)
AR (1) AR032876A1 (cg-RX-API-DMAC7.html)
AT (1) ATE346597T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002242296B2 (cg-RX-API-DMAC7.html)
BR (1) BR0207829A (cg-RX-API-DMAC7.html)
CA (1) CA2439480C (cg-RX-API-DMAC7.html)
CZ (1) CZ302412B6 (cg-RX-API-DMAC7.html)
DE (1) DE60216457T2 (cg-RX-API-DMAC7.html)
DK (1) DK1401424T3 (cg-RX-API-DMAC7.html)
ES (1) ES2275844T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0303342A3 (cg-RX-API-DMAC7.html)
IL (2) IL157588A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03007722A (cg-RX-API-DMAC7.html)
NO (1) NO20033801L (cg-RX-API-DMAC7.html)
NZ (1) NZ527991A (cg-RX-API-DMAC7.html)
PL (1) PL365021A1 (cg-RX-API-DMAC7.html)
PT (1) PT1401424E (cg-RX-API-DMAC7.html)
RS (1) RS51056B (cg-RX-API-DMAC7.html)
RU (1) RU2302240C2 (cg-RX-API-DMAC7.html)
TW (1) TWI251486B (cg-RX-API-DMAC7.html)
WO (1) WO2002067927A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL365701A1 (en) * 2000-07-21 2005-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
WO2003007934A1 (en) 2001-07-16 2003-01-30 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MXPA03007720A (es) 2001-02-27 2004-11-12 Johnson & Johnson Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad.
DE60220043T2 (de) * 2001-02-27 2008-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen
EP1744750A2 (en) * 2004-05-06 2007-01-24 Sandoz AG Pharmaceutical composition comprising hydrophobic drug having improved solubility
EP1928451B1 (en) * 2005-07-26 2011-12-28 SK Biopharmaceuticals Co., LTD Methods for treating substance-related disorders
CN101568362A (zh) * 2006-10-30 2009-10-28 詹森药业有限公司 治疗抑郁症的方法
JP2010508354A (ja) * 2006-10-31 2010-03-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 広汎性発達障害の処置
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
JP6062077B2 (ja) 2013-03-12 2017-01-18 バイオ−ファーム ソリューションズ カンパニー リミテッド 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreventingortreatingpediatricepilesyandepilesy−relatedsyndromes}
WO2014142547A1 (en) * 2013-03-12 2014-09-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for neuroprotection comprising the same
KR102900173B1 (ko) * 2016-12-14 2025-12-12 에스케이바이오팜 주식회사 조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
EP0480939B1 (en) * 1989-06-09 1995-01-25 The Upjohn Company Heterocyclic amines having central nervous system activity
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
CZ302412B6 (cs) 2011-05-04
NO20033801D0 (no) 2003-08-26
CZ20032297A3 (cs) 2004-06-16
HUP0303342A3 (en) 2012-07-30
RS67503A (sr) 2006-12-15
DK1401424T3 (da) 2007-02-26
AU2002242296B2 (en) 2006-06-29
CN1505507A (zh) 2004-06-16
NZ527991A (en) 2005-04-29
JP2004523556A (ja) 2004-08-05
DE60216457D1 (de) 2007-01-11
RS51056B (sr) 2010-10-31
RU2003128983A (ru) 2005-03-10
US20020165272A1 (en) 2002-11-07
WO2002067927A1 (en) 2002-09-06
MXPA03007722A (es) 2004-11-12
AR032876A1 (es) 2003-11-26
IL157588A0 (en) 2004-03-28
ES2275844T3 (es) 2007-06-16
KR100886578B1 (ko) 2009-03-05
PT1401424E (pt) 2007-02-28
RU2302240C2 (ru) 2007-07-10
ATE346597T1 (de) 2006-12-15
KR20030076713A (ko) 2003-09-26
HUP0303342A2 (hu) 2004-01-28
JP4276841B2 (ja) 2009-06-10
EP1401424B1 (en) 2006-11-29
EP1401424A1 (en) 2004-03-31
DE60216457T2 (de) 2007-09-20
TWI251486B (en) 2006-03-21
US6541513B2 (en) 2003-04-01
CN1262271C (zh) 2006-07-05
CA2439480C (en) 2011-04-26
PL365021A1 (en) 2004-12-27
BR0207829A (pt) 2004-06-22
IL157588A (en) 2009-12-24
CA2439480A1 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
CY1106924T1 (el) Ενωσεις καρβαμικου για χρηση οσον αφορα την προληψη ή την αγωγη των διαταραχων κινησης
CY1111349T1 (el) Καρβαμιδικες ενωσεις προς χρηση στη θεραπεια του πονου
NO20080877L (no) Fremgangsmater for behandling av substansrelaterte forstyrrelser
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
NO20072444L (no) Karbamatforbindelser for anvendelse i behandling av neurodegenerative forstyrrelser
NO20033802D0 (no) Karbamatforbindelser for anvendelse ved forebygging eller behandling av bipolar forstyrrelse
DK1368021T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af bipolær sygdom
DK1399144T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser
BR0207829A (pt) Composto de carbamato para uso na prevenção ou tratamento de distúrbios psicóticos
PT1305082E (pt) Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca
CY1109429T1 (el) Καρβαμιδικες ενωσεις για χρηση στην προληψη ή τη θεραπεια του πονου λογω νευροπαθειας
BR0211240A (pt) Compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada à cefaléia em cacho e hemicrânia
MY136347A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders
MY149385A (en) Methods for treating substance-related disorders
AR032907A1 (es) Uso de compuestos carbamatos para la prevencion o tratamiento de trastornos de ansiedad

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application